Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Immune Network|July 9, 2019
Polymeric Nanoparticles Containing Both Antigen and Vitamin D3 Induce Antigen-Specific Immune SuppressionHo-Hyun Jung, Sang-Hyun Kim, Jun-Hyeok Moon, et al.Scientific Reports|November 10, 2017
Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasoneJae-Hee Lee, Chan-Su Park, Sundong Jang, et al.Virology|August 21, 2020
Enhanced effect of modified Zika virus E antigen on the immunogenicity of DNA vaccineHyun Ju In, Yun Ha Lee, Sundong Jang, et al.Theranostics|September 15, 2020
Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.Faslpr miceHong Kyung Lee, Hyung Sook Kim, Minji Pyo, et al.Infection & Chemotherapy|April 6, 2023
Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in KoreaHeeji Lim, Sundong Jang, Hyun Ju In, et al.Vaccine|August 2, 2021
Development of an attenuated smallpox vaccine candidate: The KVAC103 strainHeeji Lim, Hyun Ju In, You-Jin Kim, et al.Frontiers in Cellular and Infection Microbiology|July 28, 2022
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination SchedulesJu-Yeon Choi, Young Jae Lee, Jae-Hoon Ko, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2022
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicitySeongman Bae, Jae-Hoon Ko, Ju-Yeon Choi, et al.Pageof 1